Revelation Biosciences, Inc. (REVBW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Analysts estimate Earnings Per Share (EPS) of $-1,436.16 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-9.44 vs est $-1,436.16 (beat +99.3%). 2025: actual $-23.95 vs est $-36.60 (beat +34.6%). Analyst accuracy: 0%.
